Salih Ehsan: Bradykinin-Mediated Transfusion Reactions in Patients on ACE Inhibitors
Salih Ehsan, Chief Executive Officer at Kulsoom Society of Hematology, shared Caitlin Raymond’s post on LinkedIn:
“Thanks for this information.
When an anemic patient comes to a transfusion center, take a look on the drugs that patient is taking regularly (ACE inhibitors, diuretics).
If the patient is taking ACE inhibitors, be ready for hypotensive transfusion reaction in the middle of transfusion.
Correct measures are:
- stop transfusion
- watch for BP, pulse, respiration, oxygen saturation, temperature, subjective feeling of patient.
If everything is okay, except BP then go for IV fluids (volume expander like normal saline).”
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared a post on LinkedIn:
“The transfusion reaction with the cleanest workup and the most interesting mechanism.
BP drops 40 points mid-transfusion.
No fever. No rash. No hemolysis.
DAT negative. Everything comes back normal.
This is a hypotensive transfusion reaction — and it’s not immunologic.
It’s pharmacologic.
Here’s what’s happening:
- Transfusion tubing and leukoreduction filters present a negatively charged surface to blood
- That contact activates Factor XII – kallikrein – bradykinin
- Bradykinin is a potent vasodilator with a half-life measured in seconds
- ACE normally clears it — but patients on ACE inhibitors can’t
- Result: bradykinin accumulates, vessels dilate, pressure drops
This is why ACE use is the most consistently identified risk factor for hypotensive transfusion reactions.
It’s not an allergy.
The drug is doing exactly what it was prescribed to do.
Management is straightforward: stop, fluids, recover.
No pre-medications indicated — Benadryl and acetaminophen do nothing for bradykinin-mediated hypotension.
The harder question is how many of these reactions we’re missing.
Hypotension is common in sick patients.
A modest BP dip in a patient on antihypertensives and diuretics may never trigger a workup.
New post on Blood Bytes Beyond.”
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 03:18Ajay Samkaria: Every Unexpected Antibody Tells a Story
-
Aug 3, 2026, 03:06Abdul Mannan: The Most Important Tube in the FXIII Assay
-
Aug 3, 2026, 02:29Herman Sandeep Prakasam: Who Is Missing Anticoagulation?
-
Aug 2, 2026, 23:07Akshat Jain: Redefining Hemophilia Readiness in Mexico
-
Aug 2, 2026, 16:24Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
-
Aug 2, 2026, 16:07Mirjavad Mammadov: Understanding the Thrombotic Paradox of Heparin Therapy
-
Aug 2, 2026, 15:49Munira Borhany: Advancing Equity in Women’s Hematological Care
-
Aug 2, 2026, 14:54Every Second Counts: How CPR and AEDs Can Save a Life – American Heart Association
-
Aug 2, 2026, 14:38New French Guidelines for Acquired Hemophilia A – CRH French Reference Center for Hemophilia Lyon